Facing coronavirus disease 2019: What do we know so far? (Review)
- PMID: 33968188
- PMCID: PMC8097225
- DOI: 10.3892/etm.2021.10090
Facing coronavirus disease 2019: What do we know so far? (Review)
Abstract
Although the World Health Organization declared the outbreak of coronavirus disease 2019 (COVID-19), which originated in China, as a public health emergency of international concern as early as January 30, 2020, the current COVID-19 epidemic is spreading rapidly. As of April 19, 2020, total of 2,392,165 confirmed cases had been reported in 211 countries and regions, with 614,421 (25.68%) cured cases and 164,391 (6.87%) deaths. Scientists and clinicians have made great efforts to learn much about COVID-19 so that it can be controlled as soon as possible. Herein, this review will discuss the epidemiology, pathology, clinical features, diagnosis and treatment of COVID-19 based on the current evidence.
Keywords: coronavirus; coronavirus disease 2019; severe acute respiratory syndrome coronavirus 2.
Copyright: © Guo et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China.Acta Virol. 2020;64(2):245-250. doi: 10.4149/av_2020_201. Acta Virol. 2020. PMID: 32551792 Review.
-
Progress of COVID-19 Epidemic in Pakistan.Asia Pac J Public Health. 2020 May;32(4):154-156. doi: 10.1177/1010539520927259. Epub 2020 May 19. Asia Pac J Public Health. 2020. PMID: 32429679 Free PMC article.
-
WHO International Health Regulations Emergency Committee for the COVID-19 outbreak.Epidemiol Health. 2020;42:e2020013. doi: 10.4178/epih.e2020013. Epub 2020 Mar 19. Epidemiol Health. 2020. PMID: 32192278 Free PMC article. Review.
-
Investigating the cases of novel coronavirus disease (COVID-19) in China using dynamic statistical techniques.Heliyon. 2020 Apr;6(4):e03747. doi: 10.1016/j.heliyon.2020.e03747. Epub 2020 Apr 4. Heliyon. 2020. PMID: 32289090 Free PMC article.
-
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.J Glob Antimicrob Resist. 2020 Jun;21:22-27. doi: 10.1016/j.jgar.2020.02.021. Epub 2020 Mar 7. J Glob Antimicrob Resist. 2020. PMID: 32156648 Free PMC article. Review.
Cited by
-
Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review.J Infect Public Health. 2021 Aug;14(8):1075-1086. doi: 10.1016/j.jiph.2021.06.013. Epub 2021 Jun 27. J Infect Public Health. 2021. PMID: 34243049 Free PMC article. Review.
-
Immune-based therapeutic approaches in COVID-19.Biomed Pharmacother. 2022 Jul;151:113107. doi: 10.1016/j.biopha.2022.113107. Epub 2022 May 16. Biomed Pharmacother. 2022. PMID: 35594701 Free PMC article. Review.
-
Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis.J Genet Eng Biotechnol. 2021 Jul 16;19(1):104. doi: 10.1186/s43141-021-00206-2. J Genet Eng Biotechnol. 2021. PMID: 34272647 Free PMC article.
-
Efficacy and Safety of Sitagliptin in the Treatment of COVID-19.J Pharm Pract. 2023 Aug;36(4):980-987. doi: 10.1177/08971900221102119. Epub 2022 May 17. J Pharm Pract. 2023. PMID: 35581701 Free PMC article. Review.
References
-
- Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. 2019. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989. Accessed December 31, 2019.
-
- WHO. Novel coronavirus (2019-nCoV) situation report 11. Jan 31, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed February 18, 2020.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous